287 related articles for article (PubMed ID: 17143262)
1. Increased expression of stem cell markers in malignant melanoma.
Klein WM; Wu BP; Zhao S; Wu H; Klein-Szanto AJ; Tahan SR
Mod Pathol; 2007 Jan; 20(1):102-7. PubMed ID: 17143262
[TBL] [Abstract][Full Text] [Related]
2. Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-Akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions.
Shanesmith RP; Smart C; Cassarino DS
Am J Dermatopathol; 2011 Oct; 33(7):663-8. PubMed ID: 21915031
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas.
Chen PL; Chen WS; Li J; Lind AC; Lu D
Mod Pathol; 2013 Jan; 26(1):44-53. PubMed ID: 22899289
[TBL] [Abstract][Full Text] [Related]
4. Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease.
Sharma BK; Manglik V; Elias EG
J Surg Res; 2010 Sep; 163(1):e11-5. PubMed ID: 20638684
[TBL] [Abstract][Full Text] [Related]
5. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma.
Mihic-Probst D; Kuster A; Kilgus S; Bode-Lesniewska B; Ingold-Heppner B; Leung C; Storz M; Seifert B; Marino S; Schraml P; Dummer R; Moch H
Int J Cancer; 2007 Oct; 121(8):1764-70. PubMed ID: 17597110
[TBL] [Abstract][Full Text] [Related]
6. [The role of intermedial filament nestin in malignant melanoma progression].
Brychtová S; Fiurásková M; Brychta T; Hirnák J
Cesk Patol; 2005 Oct; 41(4):143-5. PubMed ID: 16382989
[TBL] [Abstract][Full Text] [Related]
7. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.
Setia N; Abbas O; Sousa Y; Garb JL; Mahalingam M
Mod Pathol; 2012 Aug; 25(8):1169-75. PubMed ID: 22555176
[TBL] [Abstract][Full Text] [Related]
8. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.
Fusi A; Reichelt U; Busse A; Ochsenreither S; Rietz A; Maisel M; Keilholz U
J Invest Dermatol; 2011 Feb; 131(2):487-94. PubMed ID: 20882037
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
Sabet MN; Rakhshan A; Erfani E; Madjd Z
Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD133 and other putative stem cell markers in uveal melanoma.
Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
[TBL] [Abstract][Full Text] [Related]
11. The stem cell marker nestin predicts poor prognosis in human melanoma.
Piras F; Perra MT; Murtas D; Minerba L; Floris C; Maxia C; Demurtas P; Ugalde J; Ribatti D; Sirigu P
Oncol Rep; 2010 Jan; 23(1):17-24. PubMed ID: 19956860
[TBL] [Abstract][Full Text] [Related]
12. Nestin is highly expressed in advanced-stage melanomas and neurotized nevi.
Akiyama M; Matsuda Y; Ishiwata T; Naito Z; Kawana S
Oncol Rep; 2013 Apr; 29(4):1595-9. PubMed ID: 23417116
[TBL] [Abstract][Full Text] [Related]
13. CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients.
Gazzaniga P; Cigna E; Panasiti V; Devirgiliis V; Bottoni U; Vincenzi B; Nicolazzo C; Petracca A; Gradilone A
Eur J Surg Oncol; 2010 Dec; 36(12):1211-4. PubMed ID: 20573479
[No Abstract] [Full Text] [Related]
14. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.
Horst D; Kriegl L; Engel J; Kirchner T; Jung A
Cancer Invest; 2009 Oct; 27(8):844-50. PubMed ID: 19626493
[TBL] [Abstract][Full Text] [Related]
16. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma.
Yi L; Zhou ZH; Ping YF; Chen JH; Yao XH; Feng H; Lu JY; Wang JM; Bian XW
Mod Pathol; 2007 Oct; 20(10):1061-8. PubMed ID: 17660801
[TBL] [Abstract][Full Text] [Related]
18. [Correlation research between cancer stem cells and the pathological grades of neuroepithelial tumors].
Deng YW; Fang JS; Li MC; Chen FH; Zhou XY; Wu J; Zhou RH; Fang F; Chen C; Lu M; Zeng FY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):45-51. PubMed ID: 16562674
[TBL] [Abstract][Full Text] [Related]
19. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
20. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
